Skip to main content
  1. Home /
  2. Services /
  3. Above-Knee Arterial Occlusion Treatment - Femoropopliteal Artery

Above-Knee Arterial Occlusion Treatment - Femoropopliteal Artery

··5 mins
Assoc. Prof. Dr. Habib ÇİL
Author
Assoc. Prof. Dr. Habib ÇİL
Istanbul University Faculty of Medicine graduate, Akdeniz University Cardiology specialization. Expert in interventional cardiology, coronary angioplasty and TAVI.
Table of Contents
This content has been prepared in accordance with the Republic of Turkey Ministry of Health regulations and medical ethics rules, for the purpose of protecting public health and providing information. It does not contain any diagnosis, treatment guarantee, or referral. Please consult an authorized healthcare facility for the most accurate information.

Above-knee arterial occlusion is the narrowing or blockage of the femoropopliteal artery segment due to atherosclerosis. This area is the most common location for peripheral artery disease.

Femoropopliteal Artery Anatomy
#

The femoropopliteal segment is the longest artery segment of the leg and is subject to the most mechanical stress.

Anatomical Structure:

External Iliac Artery
        ↓
Common Femoral Artery
        ↓
     ┌──┴──┐
     ↓     ↓
  Deep      Superficial
 Femoral    Femoral Artery
(Profunda)      (SFA)
                 ↓
           Popliteal Artery
                 ↓
          ┌──────┼──────┐
          ↓      ↓      ↓
       Anterior Tibio-  Posterior
       Tibial  peroneal  Tibial

Segment Lengths:

  • Superficial femoral artery (SFA): ~30-40 cm
  • Popliteal artery: ~15-20 cm
  • Total femoropopliteal segment: ~50 cm

Why Is the Femoropopliteal Region Most Affected?
#

Mechanical Factors
#

  1. Adductor canal: The narrowest passage point for SFA
  2. Flexion stress: Repeated trauma during knee bending
  3. Long segment: Large surface area for atherosclerosis

Risk Factors
#

Risk FactorEffect
SmokingMost important risk factor
DiabetesDiffuse disease pattern
HypertensionEndothelial damage
HyperlipidemiaPlaque formation
Age >50Progressive process

Symptoms of Above-Knee Arterial Occlusion
#

Fontaine Classification
#

StageFindings
Stage IAsymptomatic
Stage IIaClaudication >200 m
Stage IIbClaudication <200 m
Stage IIIRest pain
Stage IVUlcer/Gangrene

Typical Symptoms
#

Claudication (Intermittent Limping):

  • Calf or thigh pain while walking
  • Improves in 2-5 minutes with rest
  • Starts at a certain distance
  • Earlier on slopes/stairs

Advanced Stage Symptoms:

  • Night pain (decreases when leg is lowered)
  • Cold feet
  • Trophic changes (hair loss, nail thickening)
  • Non-healing wounds

Diagnostic Methods
#

Physical Examination
#

  • Femoral and popliteal pulse palpation
  • ABI (Ankle-Brachial Index) measurement
  • Capillary refill time

ABI Assessment:

ABI ValueInterpretation
0.91-1.30Normal
0.71-0.90Mild PAD
0.41-0.70Moderate PAD
≤0.40Severe PAD/Critical ischemia

Imaging
#

Doppler Ultrasound:

  • First-line test
  • Non-invasive
  • Flow velocities and stenosis degree

CT Angiography:

  • Detailed anatomical map
  • Calcification assessment
  • Treatment planning

DSA (Digital Subtraction Angiography):

  • Gold standard
  • Treatment possible in same session

TASC II Classification (Femoropopliteal)
#

TASCLesion TypeTreatment
ASingle stenosis ≤10 cm, single occlusion ≤5 cmEndovascular
BMultiple stenoses, single occlusion ≤15 cmEndovascular
CMultiple stenoses/occlusions >15 cmEndovascular/Surgical
DChronic total occlusion (entire CFA or SFA)Surgical (primarily)

Endovascular Treatment Options
#

1. Balloon Angioplasty (PTA)
#

Conventional Balloon:

  • For short lesions
  • Low cost
  • Restenosis risk: 40-60% (1 year)

Drug-Coated Balloon (DCB):

  • Paclitaxel or Sirolimus coated
  • Prevents neointimal hyperplasia
  • Restenosis risk: 15-25% (1 year)
  • Preferred method

2. Stenting
#

Self-Expanding Nitinol Stent:

  • Long segment disease
  • Flexibility advantage
  • 1-year patency: 70-80%

Drug-Eluting Stent (DES):

  • Best long-term results
  • Low restenosis risk
  • High cost

Interwoven Stent:

  • New generation technology
  • High fracture resistance
  • Suitable for knee area

3. Atherectomy
#

Plaque removal techniques:

TypeMechanismIndication
RotationalPlaque fragmentationCalcified lesion
DirectionalPlaque cuttingEccentric plaque
OrbitalOrbital grindingHeavy calcification
LaserPhoto-ablationIn-stent restenosis

4. Chronic Total Occlusion (CTO) Crossing
#

Techniques:

  • Antegrade approach (ipsilateral)
  • Retrograde approach (from tibial arteries)
  • Subintimal angioplasty (SAFARI technique)

Success rate: 80-95% (in experienced centers)

Treatment Algorithm
#

Above-Knee Arterial Occlusion Diagnosis
                ↓
    Lifestyle modification + Medical therapy
                ↓
           Symptoms persist?
             ↙     ↘
          No       Yes
          ↓         ↓
       Follow    Lesion assessment
                      ↓
                ┌─────┼─────┐
                ↓     ↓     ↓
            <10 cm  10-25 cm  >25 cm
                ↓     ↓     ↓
             DCB   DCB/DES  Consider surgery

Treatment Outcomes
#

Primary Patency Rates
#

Treatment Method1 Year2 Years
Balloon angioplasty50-60%40-50%
Drug-coated balloon75-85%65-75%
Bare stent65-75%55-65%
Drug-eluting stent80-90%70-80%

Clinical Improvement
#

  • Claudication distance: 2-4x increase
  • Quality of life: Significant improvement
  • Limb salvage: >95%

Complications and Management
#

Early Complications
#

ComplicationFrequencyManagement
Dissection5-10%Stenting
Perforation<1%Long balloon/Covered stent
Distal embolism1-2%Aspiration/Thrombolysis
Access site complication3-5%Compression

Late Complications
#

  • Restenosis: Most common problem, reduced with DCB/DES
  • Stent fracture: Especially in knee area
  • Thrombosis: With antiplatelet non-compliance

Medical Treatment
#

For All Patients
#

  • Aspirin: 100 mg/day (lifelong)
  • Clopidogrel: 75 mg/day (at least 6 months)
  • Statin: LDL <70 mg/dL target
  • ACE inhibitor: Vascular protection
  • Smoking cessation: Mandatory

Exercise Program
#

  • Supervised walking program
  • 3 days per week, 30-45 minutes
  • Walking to claudication threshold
  • Significant benefit in 3-6 months

Surgical Treatment
#

Indications
#

  • TASC D lesions
  • Failed endovascular intervention
  • Young, active patients (for long-term patency)

Surgical Options
#

  • Femoral-popliteal bypass: Saphenous vein or synthetic graft
  • Femoral endarterectomy: Localized disease
  • Hybrid procedure: Iliac stent + Femoral bypass

Follow-up Protocol
#

Regular Checks
#

PeriodAssessment
1 monthClinical + ABI
3 monthsDoppler US
6 monthsDoppler US + ABI
12 monthsClinical + Doppler US
AfterwardsEvery 6 months

Warning Signs
#

  • Decrease in walking distance
  • New onset rest pain
  • Coldness/color change in foot

Frequently Asked Questions
#

What is above-knee arterial occlusion? +

What are the symptoms of above-knee arterial occlusion? +

How is femoropopliteal artery occlusion treated? +

What is the success rate of above-knee stenting? +

When can I walk after treatment? +

Appointment and Contact
#

To make an appointment for above-knee arterial occlusion evaluation and treatment:

Ask via WhatsApp

📍 Avrasya Hospital - Beştelsiz Mah. 101. Sokak No:107, Zeytinburnu, Istanbul

📞 Phone: +90 212 665 50 50 (Ext: 4012)


This content has been prepared by Assoc. Prof. Dr. Habib Çil for general informational purposes. Please consult a cardiology specialist for definitive diagnosis and treatment.

Related Peripheral Interventions#

Other services related to above-knee arterial occlusion treatment: